Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

OBJECTIVE: To provide the first direct comparison of patient-reported outcomes (PROs) following treatment with tofacitinib monotherapy versus tofacitinib or adalimumab (ADA) in combination with methotrexate (MTX) in patients with rheumatoid arthritis (RA) with inadequate response to MTX (MTX-IR). ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:RMD Open
Main Authors: Strand, Vibeke, Mysler, Eduardo, Moots, Robert J, Wallenstein, Gene V, DeMasi, Ryan, Gruben, David, Soma, Koshika, Iikuni, Noriko, Smolen, Josef S, Fleischmann, Roy
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6802984/
https://ncbi.nlm.nih.gov/pubmed/31673419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-001040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados